Us Tariffs

India to operationalise US trade deal only if tariff edge is secured

New Delhi wants a clear tariff advantage over competing economies and assurances against future Section 301 actions before implementing a trade agreement with Washington

Trump's trade chief says new tariffs can fit within existing deals

The EU and US agreed to a free-trade deal in July that would see the bloc erase levies on US industrial goods in exchange for a 15 per cent tariff ceiling on its exports

Trump signs order amending tariffs on steel, aluminum and copper imports

The order also allows foreign companies to qualify for a 10% tariff if 'their capital equipment includes at least 85% aluminum by weight'

India to ask US for relief from Section 301 probes as trade talks resume

The two nations reached an agreement on a trade pact earlier this year before the US Supreme Court struck down President Donald Trump's sweeping reciprocal tariffs

US may spare India from Sec 301 tariffs if deal is concluded by July 24

An official said the two countries are close to finding a solution for several non-tariff barriers

US trade officials to visit India next week to advance bilateral trade pact

A US delegation led by chief negotiator Brendan Lynch will visit India from June 1-4 to advance negotiations on the proposed bilateral trade agreement

India-US ties have not lost momentum: US Secretary of State Marco Rubio

India and the US discussed energy security, trade, immigration and Indo-Pacific maritime safety as Marco Rubio sought to reassure New Delhi on bilateral ties

India, US industry clash at USTR hearings over subsidies and overcapacity

American industry groups sought punitive tariffs on Indian goods at USTR hearings, while Indian officials defended the country's manufacturing growth as demand-led and WTO-compliant

Sitharaman, US envoy Gor discuss deepening India-US economic partnership

The finance minister and US Ambassador Sergio Gor discussed fintech collaboration, investment opportunities and bilateral economic ties amid ongoing trade negotiations

US court ruling on Trump tariffs adds uncertainty to India-US trade talks

A US trade court struck down Donald Trump's 10 per cent global tariffs, adding fresh uncertainty to India-US trade negotiations and tariff policy

Chronology of US tariffs and penalties on Indian goods since April 2025

The following is the chronology of additional or reciprocal tariffs imposed by the US on Indian goods in addition to existing duties, since April 2025. Before Apr 2, 2025: Only MFN (most favoured nation) tariffs. These are standard import duties imposed on goods from all trading partners on a non-discriminatory basis. Apr 2 - August 6, 2025: 26 per cent (10 per cent baseline tariff and 16 per cent reciprocal tariff). It was over and above MFN duties. Apr 9, 2025: US suspends tariffs for 90 days (until July 9, 2025). July 31, 2025: The US announced a 25 per cent duty to be effective from August 7, 2025. Aug 6, 2025: Additional 25 pc tariff imposed on Indian goods for the purchase of Russian oil. To be effective from August 27. Aug 7- Aug 26, 2025: 25 per cent reciprocal tariffs, over and above MFN duties. Aug 27, 2025 - Feb 6, 2026: 50 per cent tariff on Indian goods Feb 7 - Feb 23, 2026: Russia-linked 25 per cent tariffs withdrawn. A joint India-US statement indicated Washingto

India, US make 'progress' on interim trade deal, BTA negotiations

India and the US are engaged in discussions aimed at reaching a balanced and mutually beneficial trade agreement, said a spokesperson for the ministry of external affairs on Thursday

Refund process for Trump tariffs begins today after court struck them down

A refund system for businesses that paid tariffs which the US Supreme Court ruled President Donald Trump imposed without the constitutional authority to do so is scheduled to launch Monday. Importers and their brokers will be able to begin claiming refunds through an online portal beginning at 8 am, according to US Customs and Border Protection (CBP), the agency administering the system. It is the first step in a complicated process that also might eventually lead to refunds for consumers who were billed for some or all of the tariffs on products shipped to them from outside the United States. Companies must submit declarations listing the goods on which they collectively put billions of dollars toward the import taxes the court subsequently struck down. If CBP approves a claim, it will take 60-90 days for a refund to be issued, the agency said. The government expects to process refunds in phases, however, focusing first on more recent tariff payments. Any number of technical facto

India's marine products exports up, rice down in FY26: Trade data

India's marine exports rise nearly 14% in FY26 despite tariffs and war impact, while rice shipments decline amid weak prices and West Asia disruptions

IMF lifts India FY27 growth to 6.5% as lower US tariffs offset risks

IMF has raised India's FY27 growth forecast to 6.5 per cent, saying lower US tariffs could offset the impact of West Asia tensions even as global growth and trade outlook weaken

India-US trade negotiations to resume in Washington later this month

Indian delegation to visit US capital to advance interim trade pact discussions as both sides seek clarity on tariffs and non-tariff barriers

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

US pharma tariffs: CDMOs with innovator exposure likely to take a hit

Proposed US tariffs on patented drugs may pressure innovators to shift production locally, creating uncertainty for Indian CDMOs even as generics-led exports remain largely insulated

India likely to stay insulated from Trump's tariff shock on patented drugs

US tariffs on patented drugs may have limited immediate impact on India, but industry flags uncertainty as policy ties relief to pricing and manufacturing shifts

Trump imposes 100% tariff on patented drug imports; generics spared

The US has announced a 100 per cent tariff on patented pharma imports from countries like India without reshoring deals, aiming to boost local production, while generics have been exempted for now